Anti-Car-Engineered T Cells for Epitope-Based Elimination of Autologous CAR T Cells

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/s00262-019-02376-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Engineering CAR-T Cells

Biomarker Research
BiochemistryMolecular MedicineClinical Biochemistry
2017English

Improved Survival of CAR‐T and Tumor‐specific T Cells Caused by Anti‐PD‐1 scFv‐producing CAR‐T Cells

Cancer Science
Cancer ResearchMedicineOncology
2019English

CAR T Cells for Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2019English

Targeting Glioblastoma With CAR T Cells

Cancer Discovery
Oncology
2017English

Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors

OncoImmunology
OncologyAllergyImmunology
2013English

Tracing the Path of CAR T Cells

Cancer Discovery
Oncology
2017English

Armed T Cells With CAR for Cancer Immunotherapy

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2016English

CAR T-Cells: Costs, Comparisons and Commentary

Journal of Medical Economics
Health Policy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy